93 related articles for article (PubMed ID: 17900591)
1. Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study.
Troughton JA; Woodside JV; Yarnell JW; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Luc G;
Atherosclerosis; 2008 Apr; 197(2):556-63. PubMed ID: 17900591
[TBL] [Abstract][Full Text] [Related]
2. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME).
Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):79-84. PubMed ID: 17301631
[TBL] [Abstract][Full Text] [Related]
3. [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):808-13. PubMed ID: 17299970
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine and coronary heart disease risk in the PRIME study.
Troughton JA; Woodside JV; Young IS; Arveiler D; Amouyel P; Ferrières J; Ducimetière P; Patterson CC; Kee F; Yarnell JW; Evans A;
Atherosclerosis; 2007 Mar; 191(1):90-7. PubMed ID: 16774755
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
van Himbergen TM; van der Schouw YT; Voorbij HA; van Tits LJ; Stalenhoef AF; Peeters PH; Roest M
Atherosclerosis; 2008 Aug; 199(2):408-14. PubMed ID: 18164014
[TBL] [Abstract][Full Text] [Related]
6. The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.
Domagała TB; Łacinski M; Trzeciak WH; Mackness B; Mackness MI; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):4-10. PubMed ID: 17543199
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
8. Fasting insulin concentrations and coronary heart disease incidence in France and Northern Ireland: the PRIME Study.
Bataille V; Perret B; Troughton J; Amouyel P; Arveiler D; Woodside J; Dallongeville J; Haas B; Bingham A; Ducimetière P; Ferrières J
Int J Cardiol; 2006 Apr; 108(2):189-96. PubMed ID: 15925416
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
Stevens VL; Rodriguez C; Talbot JT; Pavluck AL; Thun MJ; Calle EE
Prostate; 2008 Sep; 68(12):1336-40. PubMed ID: 18500687
[TBL] [Abstract][Full Text] [Related]
10. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study.
Yarnell J; Yu S; McCrum E; Arveiler D; Hass B; Dallongeville J; Montaye M; Amouyel P; Ferrières J; Ruidavets JB; Evans A; Bingham A; Ducimetière P;
Int J Epidemiol; 2005 Apr; 34(2):268-75. PubMed ID: 15319403
[TBL] [Abstract][Full Text] [Related]
11. The effects of age and gender on the relationship between HMGCR promoter-911 SNP (rs33761740) and serum lipids in patients with coronary heart disease.
Akadam-Teker B; Kurnaz O; Coskunpinar E; Daglar-Aday A; Kucukhuseyin O; Cakmak HA; Teker E; Bugra Z; Ozturk O; Yilmaz-Aydogan H
Gene; 2013 Oct; 528(2):93-8. PubMed ID: 23933271
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase gene Q192R & L55M polymorphisms in Indians with acute myocardial infarction & association with oxidized low density lipoprotein.
Lakshmy R; Ahmad D; Abraham RA; Sharma M; Vemparala K; Das S; Reddy KS; Prabhakaran D
Indian J Med Res; 2010 Apr; 131():522-9. PubMed ID: 20424303
[TBL] [Abstract][Full Text] [Related]
13. Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary heart disease risk after a 10-year follow-up in a Mediterranean cohort: Modulation by alcohol consumption.
Corella D; Carrasco P; Amiano P; Arriola L; Chirlaque MD; Huerta JM; Martínez C; Martinez-Camblor P; Molina E; Navarro C; Quirós JR; Rodríguez L; Sánchez MJ; Ortega-Azorín C; Ros E; Sala N; González CA; Moreno C
Atherosclerosis; 2010 Aug; 211(2):531-8. PubMed ID: 20398902
[TBL] [Abstract][Full Text] [Related]
14. Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study.
Watzinger N; Schmidt H; Schumacher M; Schmidt R; Eber B; Fruhwald FM; Zweiker R; Kostner GM; Klein W
Cardiology; 2002; 98(3):116-22. PubMed ID: 12417809
[TBL] [Abstract][Full Text] [Related]
15. Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Luc G; Bard JM; Ferrières J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetière P
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1155-61. PubMed ID: 12117731
[TBL] [Abstract][Full Text] [Related]
16. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 polymorphisms and risk of myocardial infarction in women and men.
Mukamal KJ; Pai JK; Jensen MK; Rimm EB
Circ J; 2009 Jul; 73(7):1302-7. PubMed ID: 19443958
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase-1 L55M polymorphism is associated with an abnormal oral glucose tolerance test and differentiates high risk coronary disease families.
Deakin S; Leviev I; Nicaud V; Brulhart Meynet MC; Tiret L; James RW;
J Clin Endocrinol Metab; 2002 Mar; 87(3):1268-73. PubMed ID: 11889198
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of the influence of paraoxonase 1 activity and coronary heart disease risk.
Wang M; Lang X; Cui S; Zou L; Cao J; Wang S; Wu X
DNA Cell Biol; 2012 Jun; 31(6):975-82. PubMed ID: 22320866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
